Monday, December 14, 2015

JAMA - "Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products"

"Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products"

"Conclusions and Relevance  Among patients in the US Medicare nondialysis population with first exposure to IV iron, the risk of anaphylaxis was highest for iron dextran and lowest for iron sucrose.

http://jama.jamanetwork.com/article.aspx?articleid=2470447

No comments:

Post a Comment